DOCSLIB.ORG

Circle One: A1 A2 SCORE ___/16 MULTIPLE CHOICE Ci

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Circle One: A1 A2 SCORE ___/16 MULTIPLE CHOICE Ci NAME _______________________________________ Circle One: A1 A2 SCORE _____________ /16 MULTIPLE CHOICE Circle the best answer for questions 1-10 (1 pt each) 1. A piece of double stranded DNA has 30% A, what will be the % of G? a. 30% b. 40% c. 20% d. 70% e. not enough information to answer 2. You have a piece of DNA with the sequence ATGC. From this you know, a. A is at the 5’ end b. A is at the 3’ end c. A could be at either the 5’ end or the 3’ end of DNA d. You have a palindromic sequence e. None of the above 3. Which of the following bases pairs with guanine? a. Adenine b. Guanine c. Cytosine d. Uracil e. Thymine 4. The nitrogenous base is linked to the ribose or deoxyribose sugar via a a. Glycosidic bond b. Amide bond c. Hydrogen bond d. Phosphoanhydride bond e. Phosphodiester bond 5. Genomic DNA is _______ resulting in the production of _______. a. Transcribed mRNA b. Translated, tRNA c. Transcribed, DNA d. Translated, protein e. Replicated, mRNA 2 6. _______ is the adaptor that is key to converting the triplet codons of mRNA into the protein polymers. a. tRNA b. rRNA c. mRNA d. siRNA e. lcRNA 7. Which of the following statements about double-stranded DNA is false? a. The backbone contains alternating ribose sugar and phosphate groups. b. The two strands have an antiparallel orientation. c. The helix has two grooves called the major groove and the minor groove. d. The bases are on the outside of the helix. e. The strands are formed by nucleotides linked together via phosphodiester bonds. 8. In the picture below, arrow labeled 1 corresponds to ______ and arrow 2 corresponds to _________. a. Replication, transcription b. Translation, transcription c. Mutation, replication d. Transcription, replication e. Transcription, translation 9. In the picture below, which label(s) on the left refer to the template strand? a. 1 b. 2 c. mRNA d. both 1 and 2 are template strands e. both 1 and mRNA are the template strands 10. Which of the following statements are TRUE? a. The mRNA is translated from 5’ to the 3’ end b. The mRNA is translated from 3’ to 5’ end c. During transcription, the mRNA is synthesized in the 3’à5’ direction d. A and C are both true e. B and C are both true 3 SHORT ANSWER. Follow directions with each question. 11. For the base pair shown below, answer the following questions. (6 pts) O NH2 N HN N O N N N O O O O H H H H H H O H H H H O a. Shown above is (circle all that apply). Adenosine Guanosine Cytidine Uridine Thymidine b. Draw hydrogen bonds between the bases as dashed or dotted lines. c. CIRCLE the group that is the major difference between uridine and thymine. d. Draw an arrow to the glycosidic linkage of the purine. e. Draw a square around the 5’-carbon of the pyrimidine. 12. The following piece of double stranded DNA encodes a very short peptide. In the space below, write the sequence of mRNA that would be synthesized by RNA polymerase from this piece of DNA if the bottom strand is the template. Then write the protein sequence in one-letter code that would be synthesized by the ribosome from that mRNA using the first reading frame (use Genetic Code Table below). (0 pts) 5’- ATGGCTGGGTGCTTTTAA-3’ 3’ –TACCGACCCACGAAAATT-5’ mRNA sequence: AUG GCU GGG UGC UUU UAA Protein sequence: MAGCF .
Load more

Recommended publications
  • Rnase a Cleanup of DNA Samples Version Number: 1.0 Version 1.0 Date: 12/21/2016 Author(S): Yuko Yoshinaga, Eileen Dalin Reviewed/Revised By
    SAMPLE MANAGEMENT STANDARD OPERATING PROCEDURE RNase A Cleanup of DNA Samples Version Number: 1.0 Version 1.0 Date: 12/21/2016 Author(s): Yuko Yoshinaga, Eileen Dalin Reviewed/Revised by: Summary RNase A treatment is used for the removal of RNA from genomic DNA samples. RNase A cleaves the phosphodiester bond between the 5'-ribose of a nucleotide and the phosphate group attached to the 3'- ribose of an adjacent pyrimidine nucleotide. The resulting 2', 3'-cyclic phosphate is hydrolyzed to the corresponding 3'-nucleoside phosphate. Materials & Reagents Materials Vendor Stock Number Disposables 1.5 ml microcentrifuge tubes Reagents TE Buffer, pH 8.0 Ambion 9849 RNase A, DNase and protease-free (10 mg/ml) ThermoFisher EN0531 Sodium acetate buffer solution (3M, pH 5.2) VWR 567422 Ethanol, 200 proof Pharmco-Aaper 111000200CSPP 50x TAE Buffer Life Technologies/ Invitrogen MRGF-4210 SYBR® Safe DNA gel stain (10,000x concentrate in Life Technologies/ Invitrogen S33102 DMSO) DNA Molecular Weight Marker II Sigma 10236250001 Gel Loading Dye, Blue (6x) New England BioLabs B7021S Equipment Centrifuge 4°C Heat block 37°C Gel electrophoresis device Gel Imager Bio-Rad EH&S PPE Requirements: 1.1 Safety glasses, lab coat, and nitrile gloves should be worn at all times while performing work in the lab during this protocol. 1.2 Ethanol is a highly flammable and irritating to the eyes. Vapors may cause drowsiness and dizziness. Keep containers closed and keep away from sources of ignition such as smoking. 1 SAMPLE MANAGEMENT STANDARD OPERATING PROCEDURE Avoid contact with skin and eyes. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
    [Show full text]
  • Secretariat of the CBD Technical Series No. 82 Convention on Biological Diversity
    Secretariat of the CBD Technical Series No. 82 Convention on Biological Diversity 82 SYNTHETIC BIOLOGY FOREWORD To be added by SCBD at a later stage. 1 BACKGROUND 2 In decision X/13, the Conference of the Parties invited Parties, other Governments and relevant 3 organizations to submit information on, inter alia, synthetic biology for consideration by the Subsidiary 4 Body on Scientific, Technical and Technological Advice (SBSTTA), in accordance with the procedures 5 outlined in decision IX/29, while applying the precautionary approach to the field release of synthetic 6 life, cell or genome into the environment. 7 Following the consideration of information on synthetic biology during the sixteenth meeting of the 8 SBSTTA, the Conference of the Parties, in decision XI/11, noting the need to consider the potential 9 positive and negative impacts of components, organisms and products resulting from synthetic biology 10 techniques on the conservation and sustainable use of biodiversity, requested the Executive Secretary 11 to invite the submission of additional relevant information on this matter in a compiled and synthesised 12 manner. The Secretariat was also requested to consider possible gaps and overlaps with the applicable 13 provisions of the Convention, its Protocols and other relevant agreements. A synthesis of this 14 information was thus prepared, peer-reviewed and subsequently considered by the eighteenth meeting 15 of the SBSTTA. The documents were then further revised on the basis of comments from the SBSTTA 16 and peer review process, and submitted for consideration by the twelfth meeting of the Conference of 17 the Parties to the Convention on Biological Diversity.
    [Show full text]
  • The Grammar of Transcriptional Regulation
    Hum Genet (2014) 133:701–711 DOI 10.1007/s00439-013-1413-1 REVIEW PAPER The grammar of transcriptional regulation Shira Weingarten-Gabbay · Eran Segal Received: 11 June 2013 / Accepted: 24 December 2013 / Published online: 5 January 2014 © Springer-Verlag Berlin Heidelberg 2014 Abstract Eukaryotes employ combinatorial strategies to regulatory motifs (Levine and Tjian 2003) and exploit motif generate a variety of expression patterns from a relatively geometry as another dimension of combinatorial power small set of regulatory DNA elements. As in any other lan- for regulating transcription. Understanding the fundamen- guage, deciphering the mapping between DNA and expres- tal principles governing transcriptional regulation could sion requires an understanding of the set of rules that govern allow us to predict expression from DNA sequence, with basic principles in transcriptional regulation, the functional far-reaching implications. Most notably, in many human elements involved, and the ways in which they combine to diseases, genetic changes occur in non-coding regions such orchestrate a transcriptional output. Here, we review the cur- as gene promoters and enhancers. However, without under- rent understanding of various grammatical rules, including standing the grammar of transcriptional regulation, we the effect on expression of the number of transcription factor cannot tell which sequence changes affect expression and binding sites, their location, orientation, affinity and activity; how. For example, even for a single binding site, we do not co-association with different factors; and intrinsic nucleo- know the quantitative effects on expression of its location, some organization. We review different methods that are orientation, and affinity; whether these effects are general, used to study the grammar of transcription regulation, high- factor-specific, and/or promoter-dependent; and how they light gaps in current understanding, and discuss how recent depend on the intrinsic nucleosome organization.
    [Show full text]
  • U6 Small Nuclear RNA Is Transcribed by RNA Polymerase III (Cloned Human U6 Gene/"TATA Box"/Intragenic Promoter/A-Amanitin/La Antigen) GARY R
    Proc. Nati. Acad. Sci. USA Vol. 83, pp. 8575-8579, November 1986 Biochemistry U6 small nuclear RNA is transcribed by RNA polymerase III (cloned human U6 gene/"TATA box"/intragenic promoter/a-amanitin/La antigen) GARY R. KUNKEL*, ROBIN L. MASERt, JAMES P. CALVETt, AND THORU PEDERSON* *Cell Biology Group, Worcester Foundation for Experimental Biology, Shrewsbury, MA 01545; and tDepartment of Biochemistry, University of Kansas Medical Center, Kansas City, KS 66103 Communicated by Aaron J. Shatkin, August 7, 1986 ABSTRACT A DNA fragment homologous to U6 small 4A (20) was screened with a '251-labeled U6 RNA probe (21, nuclear RNA was isolated from a human genomic library and 22) using a modified in situ plaque hybridization protocol sequenced. The immediate 5'-flanking region of the U6 DNA (23). One of several positive clones was plaque-purified and clone had significant homology with a potential mouse U6 gene, subsequently shown by restriction mapping to contain a including a "TATA box" at a position 26-29 nucleotides 12-kilobase-pair (kbp) insert. A 3.7-kbp EcoRI fragment upstream from the transcription start site. Although this containing U6-hybridizing sequences was subcloned into sequence element is characteristic of RNA polymerase II pBR322 for further restriction mapping. An 800-base-pair promoters, the U6 gene also contained a polymerase III "box (bp) DNA fragment containing U6 homologous sequences A" intragenic control region and a typical run of five thymines was excised using Ava I and inserted into the Sma I site of at the 3' terminus (noncoding strand). The human U6 DNA M13mp8 replicative form DNA (M13/U6) (24).
    [Show full text]
  • Technical Glossary
    WBVGL 6/28/03 12:00 AM Page 409 Technical Glossary abortive infection: Infection of a cell where there is no net increase in the production of infectious virus. abortive transformation: See transitory (transient or abortive) transformation. acid blob activator: A regulatory protein that acts in trans to alter gene expression and whose activity depends on a region of an amino acid sequence containing acidic or phosphorylated residues. acquired immune deficiency syndrome (AIDS): A disease characterized by loss of cell-mediated and humoral immunity as the result of infection with human immunodeficiency virus (HIV). acute infection: An infection marked by a sudden onset of detectable symptoms usually followed by complete or apparent recovery. adaptive immunity (acquired immunity): See immunity. adjuvant: Something added to a drug to increase the effectiveness of that drug. With respect to the immune system, an adjuvant increases the response of the system to a particular antigen. agnogene: A region of a genome that contains an open reading frame of unknown function; origi- nally used to describe a 67- to 71-amino acid product from the late region of SV40. AIDS: See acquired immune deficiency syndrome. aliquot: One of a number of replicate samples of known size. a-TIF: The alpha trans-inducing factor protein of HSV; a structural (virion) protein that functions as an acid blob transcriptional activator. Its specificity requires interaction with certain host cel- lular proteins (such as Oct1) that bind to immediate-early promoter enhancers. ambisense genome: An RNA genome that contains sequence information in both the positive and negative senses. The S genomic segment of the Arenaviridae and of certain genera of the Bunyaviridae have this characteristic.
    [Show full text]
  • Expanding the Genetic Code Lei Wang and Peter G
    Reviews P. G. Schultz and L. Wang Protein Science Expanding the Genetic Code Lei Wang and Peter G. Schultz* Keywords: amino acids · genetic code · protein chemistry Angewandte Chemie 34 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim DOI: 10.1002/anie.200460627 Angew. Chem. Int. Ed. 2005, 44,34–66 Angewandte Protein Science Chemie Although chemists can synthesize virtually any small organic molecule, our From the Contents ability to rationally manipulate the structures of proteins is quite limited, despite their involvement in virtually every life process. For most proteins, 1. Introduction 35 modifications are largely restricted to substitutions among the common 20 2. Chemical Approaches 35 amino acids. Herein we describe recent advances that make it possible to add new building blocks to the genetic codes of both prokaryotic and 3. In Vitro Biosynthetic eukaryotic organisms. Over 30 novel amino acids have been genetically Approaches to Protein encoded in response to unique triplet and quadruplet codons including Mutagenesis 39 fluorescent, photoreactive, and redox-active amino acids, glycosylated 4. In Vivo Protein amino acids, and amino acids with keto, azido, acetylenic, and heavy-atom- Mutagenesis 43 containing side chains. By removing the limitations imposed by the existing 20 amino acid code, it should be possible to generate proteins and perhaps 5. An Expanded Code 46 entire organisms with new or enhanced properties. 6. Outlook 61 1. Introduction The genetic codes of all known organisms specify the same functional roles to amino acid residues in proteins. Selectivity 20 amino acid building blocks. These building blocks contain a depends on the number and reactivity (dependent on both limited number of functional groups including carboxylic steric and electronic factors) of a particular amino acid side acids and amides, a thiol and thiol ether, alcohols, basic chain.
    [Show full text]
  • Unitary Structure of Palindromes in DNA
    bioRxiv preprint doi: https://doi.org/10.1101/2021.07.21.453288; this version posted July 22, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Unitary Structure of Palindromes in DNA Mehmet Ali Tibatan1, ∗ and Mustafa Sarısaman2, y 1Department of Biotechnology, Istanbul University, 34134, Vezneciler, Istanbul, Turkey 2Department of Physics, Istanbul University, 34134, Vezneciler, Istanbul, Turkey We investigate the quantum behavior encountered in palindromes within DNA structure. In par- ticular, we reveal the unitary structure of usual palindromic sequences found in genomic DNAs of all living organisms, using the Schwinger’s approach. We clearly demonstrate the role played by palin- dromic configurations with special emphasis on physical symmetries, in particular subsymmetries of unitary structure. We unveil the prominence of unitary structure in palindromic sequences in the sense that vitally significant information endowed within DNA could be transformed unchangeably in the process of transcription. We introduce a new symmetry relation, namely purine-purine or pyrimidine-pyrimidine symmetries (p-symmetry) in addition to the already known symmetry rela- tion of purine-pyrimidine symmetries (pp-symmetry) given by Chargaff’s rule. Therefore, important vital functions of a living organisms are protected by means of these symmetric features. It is un- derstood that higher order palindromic sequences could be generated in terms of the basis of the highest prime numbers that make up the palindrome sequence number. We propose that violation of this unitary structure of palindromic sequences by means of our proposed symmetries leads to a mutation in DNA, which could offer a new perspective in the scientific studies on the originand cause of mutation.
    [Show full text]
  • Palindromes in DNA—A Risk for Genome Stability and Implications in Cancer
    International Journal of Molecular Sciences Review Palindromes in DNA—A Risk for Genome Stability and Implications in Cancer Marina Svetec Mikleni´cand Ivan Krešimir Svetec * Faculty of Food Technology and Biotechnology, University of Zagreb, Pierottijeva 6, 10000 Zagreb, Croatia; [email protected] * Correspondence: [email protected]; Tel.: +385-1483-6016 Abstract: A palindrome in DNA consists of two closely spaced or adjacent inverted repeats. Certain palindromes have important biological functions as parts of various cis-acting elements and protein binding sites. However, many palindromes are known as fragile sites in the genome, sites prone to chromosome breakage which can lead to various genetic rearrangements or even cell death. The ability of certain palindromes to initiate genetic recombination lies in their ability to form secondary structures in DNA which can cause replication stalling and double-strand breaks. Given their recombinogenic nature, it is not surprising that palindromes in the human genome are involved in genetic rearrangements in cancer cells as well as other known recurrent translocations and deletions associated with certain syndromes in humans. Here, we bring an overview of current understanding and knowledge on molecular mechanisms of palindrome recombinogenicity and discuss possible implications of DNA palindromes in carcinogenesis. Furthermore, we overview the data on known palindromic sequences in the human genome and efforts to estimate their number and distribution, as well as underlying mechanisms of genetic rearrangements specific palindromic sequences cause. Keywords: DNA palindromes; quasipalindromes; palindromic amplification; palindrome-mediated genetic recombination; carcinogenesis Citation: Svetec Mikleni´c,M.; Svetec, I.K. Palindromes in DNA—A Risk for Genome Stability and Implications in Cancer.
    [Show full text]
  • Molecular Biology and Applied Genetics
    MOLECULAR BIOLOGY AND APPLIED GENETICS FOR Medical Laboratory Technology Students Upgraded Lecture Note Series Mohammed Awole Adem Jimma University MOLECULAR BIOLOGY AND APPLIED GENETICS For Medical Laboratory Technician Students Lecture Note Series Mohammed Awole Adem Upgraded - 2006 In collaboration with The Carter Center (EPHTI) and The Federal Democratic Republic of Ethiopia Ministry of Education and Ministry of Health Jimma University PREFACE The problem faced today in the learning and teaching of Applied Genetics and Molecular Biology for laboratory technologists in universities, colleges andhealth institutions primarily from the unavailability of textbooks that focus on the needs of Ethiopian students. This lecture note has been prepared with the primary aim of alleviating the problems encountered in the teaching of Medical Applied Genetics and Molecular Biology course and in minimizing discrepancies prevailing among the different teaching and training health institutions. It can also be used in teaching any introductory course on medical Applied Genetics and Molecular Biology and as a reference material. This lecture note is specifically designed for medical laboratory technologists, and includes only those areas of molecular cell biology and Applied Genetics relevant to degree-level understanding of modern laboratory technology. Since genetics is prerequisite course to molecular biology, the lecture note starts with Genetics i followed by Molecular Biology. It provides students with molecular background to enable them to understand and critically analyze recent advances in laboratory sciences. Finally, it contains a glossary, which summarizes important terminologies used in the text. Each chapter begins by specific learning objectives and at the end of each chapter review questions are also included.
    [Show full text]
  • "Modified" RNA (And DNA) World
    July editorial The "modified" RNA (and DNA) world A few months ago, as COVID-19 vaccinations were getting underway in the U.S., a non-scientist friend said he was uneasy because had heard that the RNA in them had been "doped". Leaning in, I asked "How?" (I knew of course, vide infra). "With some chemical" he replied. This struck me as a perfect storm of an educated, reasonably informed non- scientist being led astray by how the media often doesn't get it quite right, though we all recognize that too much detail can be narcoleptic. The art is to convey the science in just the right dose, as Lewis Thomas and Carl Sagan did for example (1). I told my friend what the "doping" was, using lay terms. He listened thoughtfully and then I came in with my final shot: nature is full of RNA that is "doped", and even DNA is as well. These chemical modifications are not done by mad scientists but the very biological systems in which these RNAs and DNAs reside, using their own enzymes. He left somewhat convinced and hopefully is now vaccinated. This encounter gave me the thought that I, and my readers, should take a step back and think about all the "modified" RNAs and DNAs out there. For transfer RNAs alone, there are 120 known base modifications, with their prevalence as high as 13 of the 76 nucleotides in human cytosolic tRNAtyr(2). N6- adenosine methylation of messenger RNA, discovered in 1974, has recently come to the fore, although not all experts agree on its functional significance (3,4).
    [Show full text]
  • Chapter 3. the Beginnings of Genomic Biology – Molecular
    Chapter 3. The Beginnings of Genomic Biology – Molecular Genetics Contents 3. The beginnings of Genomic Biology – molecular genetics 3.1. DNA is the Genetic Material 3.6.5. Translation initiation, elongation, and termnation 3.2. Watson & Crick – The structure of DNA 3.6.6. Protein Sorting in Eukaryotes 3.3. Chromosome structure 3.7. Regulation of Eukaryotic Gene Expression 3.3.1. Prokaryotic chromosome structure 3.7.1. Transcriptional Control 3.3.2. Eukaryotic chromosome structure 3.7.2. Pre-mRNA Processing Control 3.3.3. Heterochromatin & Euchromatin 3.4. DNA Replication 3.7.3. mRNA Transport from the Nucleus 3.4.1. DNA replication is semiconservative 3.7.4. Translational Control 3.4.2. DNA polymerases 3.7.5. Protein Processing Control 3.4.3. Initiation of replication 3.7.6. Degradation of mRNA Control 3.4.4. DNA replication is semidiscontinuous 3.7.7. Protein Degradation Control 3.4.5. DNA replication in Eukaryotes. 3.8. Signaling and Signal Transduction 3.4.6. Replicating ends of chromosomes 3.8.1. Types of Cellular Signals 3.5. Transcription 3.8.2. Signal Recognition – Sensing the Environment 3.5.1. Cellular RNAs are transcribed from DNA 3.8.3. Signal transduction – Responding to the Environment 3.5.2. RNA polymerases catalyze transcription 3.5.3. Transcription in Prokaryotes 3.5.4. Transcription in Prokaryotes - Polycistronic mRNAs are produced from operons 3.5.5. Beyond Operons – Modification of expression in Prokaryotes 3.5.6. Transcriptions in Eukaryotes 3.5.7. Processing primary transcripts into mature mRNA 3.6. Translation 3.6.1.
    [Show full text]
  • Evaluation of the Quality, Safety and Efficacy of Messenger RNA
    1 2 3 WHO/BS/2021.2402 4 ENGLISH ONLY 5 6 7 8 9 Evaluation of the quality, safety and efficacy of messenger RNA vaccines for 10 the prevention of infectious diseases: regulatory considerations 11 12 13 14 15 16 NOTE: 17 18 This draft document has been prepared for the purpose of inviting comments and suggestions on 19 the proposals contained therein which will then be considered by the WHO Expert Committee on 20 Biological Standardization (ECBS). The distribution of this draft document is intended to 21 provide information on the proposed document: Evaluation of the quality, safety and efficacy of 22 messenger RNA vaccines for the prevention of infectious diseases: regulatory considerations to a 23 broad audience and to ensure the transparency of the consultation process. 24 25 The text in its present form does not necessarily represent the agreed formulation of the 26 ECBS. Written comments proposing modifications to this text MUST be received by 17 27 September 2021 using the Comment Form available separately and should be addressed to 28 the Department of Health Products Policy and Standards, World Health Organization, 20 Avenue 29 Appia, 1211 Geneva 27, Switzerland. Comments may also be submitted electronically to the 30 Responsible Officer: Dr Tiequn Zhou at: [email protected]. 31 32 The outcome of the deliberations of the Expert Committee will be published in the WHO 33 Technical Report Series. The final agreed formulation of the document will be edited to be in 34 conformity with the second edition of the WHO style guide (KMS/WHP/13.1).
    [Show full text]